BEAWARE investigated the pattern of first-line bevacizumab early interruption in the Italian real-world setting of metastatic colorectal cancer.
Discontinuation of first-line bevacizumab in metastatic colorectal cancer: the BEAWARE Italian Observational Study
Ballestrero, Alberto;
2019-01-01
Abstract
BEAWARE investigated the pattern of first-line bevacizumab early interruption in the Italian real-world setting of metastatic colorectal cancer.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
LONARDI 2019 BEAWARE Italian Observational Study.pdf
accesso aperto
Tipologia:
Documento in versione editoriale
Dimensione
134.19 kB
Formato
Adobe PDF
|
134.19 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
